Compare Alliant Energy Corporation (LNT) vs Maravai LifeSciences Holdings Inc. Class A Common Stock (MRVI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Alliant Energy Corporation vs Maravai LifeSciences Holdings Inc. Class A Common Stock — how do they compare? Alliant Energy Corporation trades at $67.7 (market cap $17.51B), while Maravai LifeSciences Holdings Inc. Class A Common Stock trades at $6.56 (market cap $977.37M). The key difference: Alliant Energy Corporation is far larger — about 17.9× Maravai LifeSciences Holdings Inc. Class A Common Stock's market cap, and Alliant Energy Corporation pays a 3.17% dividend while Maravai LifeSciences Holdings Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Alliant Energy Corporation for 65 Days and Maravai LifeSciences Holdings Inc. Class A Common Stock for 0 Days on average.
| LNT | MRVI | |
|---|---|---|
Market Cap | $17.51B | $977.37M |
Volume | 2,397,331 | 2,742,564 |
Sector | Utilities | Health |
52-Week High | $78.03 | $9.00 |
52-Week Low | $63.21 | $2.83 |
Typical Hold Time | 65 Days | 0 Days |
Enterprise Value | $29.60B | $1.08B |
Dividend Yield | 3.17% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
LNT trades at $66.96, up 0.75% today, with a bullish technical signal despite mixed momentum indicators. The company shows strong fundamentals with Q2 2026 EPS beating expectations at $0.65 versus $0.579, and revenue growth to $4.36B in 2025. Recent news highlights a $1.4B partnership with CareTrust REIT and institutional buying interest.
Outlook remains positive with analyst consensus price target of $74.00 (10.5% upside) and no sell ratings. Key risks include rising debt levels (debt-to-asset ratio up to 48.48% in 2025) and execution of $13.4B capital expenditure plan. The stock offers defensive utility exposure with 23-year dividend growth.
Maravai LifeSciences (MRVI) trades at $6.53, down 7.51% in the last session amid mixed signals. The stock shows improving fundamentals with Q2 2026 revenue growth of 9% and three consecutive earnings beats, though it remains unprofitable with a -37.07% net margin. Technical analysis indicates neutral positioning with key support at $6 and resistance at $7. Recent news highlights patent expansions in China and institutional accumulation.
The outlook remains cautiously optimistic with analyst consensus pointing to 7% upside potential to the $7.00 price target. Key opportunities include margin expansion and RNA technology leadership, while risks center on persistent cash burn and competitive pressures in life sciences. The stock offers speculative growth potential for risk-tolerant investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Alliant Energy Corporation
Alliant Energy is the parent of two regulated utilities, Interstate Power and Light and Wisconsin Power and Light, serving nearly 1 million electricity and natural gas customers and approximately 420,000 natural gas-only customers. Both subsidiaries engage in the generation and distribution of electricity and the distribution and transportation of natural gas. Alliant also owns a 16% interest in American Transmission Co.
Read more on LNT →About Maravai LifeSciences Holdings Inc. Class A Common Stock
Maravai LifeSciences Holdings Inc. is a life sciences company supporting drug therapy, diagnostic, and vaccine development through four operating brands: TriLink BioTechnologies (nucleic acid and mRNA synthesis), Cygnus Technologies (biologics safety testing), Glen Research (oligonucleotide synthesis materials), and Alphazyme (enzyme manufacturing). It serves biotech and biopharma customers from discovery through commercial manufacturing.
Read more on MRVI →
